Shareholders elect directors with majority support; Nasdaq confirms audit committee compliance

Adaptive Biotechnologies Corp

Peter Neupert elected with 69.15% for (30.85% withhold); Michelle Griffin with 82.93% for.
Advisory vote on 2023 executive compensation passed with 86% support.
Ratification of Ernst & Young as independent auditor for FY2024 passed with 99.6% approval.
Nasdaq confirmed compliance with Listing Rule 5605(c)(2) after Peter Neupert joined audit committee in July 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.